Nuvectis Pharma
NVCT
NVCT
53 hedge funds and large institutions have $22.2M invested in Nuvectis Pharma in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Holders
53
Holding in Top 10
–
Calls
$1.01M
Puts
–
Top Buyers
| 1 | +$275K | |
| 2 | +$272K | |
| 3 | +$255K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$243K |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$198K |
Top Sellers
| 1 | -$319K | |
| 2 | -$233K | |
| 3 | -$112K | |
| 4 |
MG
Marex Group
London,
|
-$112K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$94.5K |
